Antiviral activity, pharmacokinetics and safety of the second-generation hepatitis B core inhibitor ABI-H2158 in Phase 1b study of patients with HBeAg-positive chronic hepatitis B infection
Authors:
- Kosh AgarwalKAKosh Agarwal
- Junqi NiuJNJunqi Niu
- Yanhua DingYDYanhua Ding
- Edward GaneEGEdward Gane
- Tuan NguyenTNTuan Nguyen
- Katia AlvesKAKatia Alves
- Marc EvanchickMEMarc Evanchick
- Hany ZayedHZHany Zayed
- Qi HuangQHQi Huang
- Steven KnoxSKSteven Knox
- Luisa StammLSLuisa Stamm
- Richard ColonnoRCRichard Colonno
- 1 August 2020
- journal article
- abstracts
- Published by Elsevier in Journal of Hepatology
- Vol. 73, S125